{"id":"W1998549443","doi":"10.1016/j.rmed.2005.05.024","title":"Once-daily ciclesonide 80 or 320 μg for 12 weeks is safe and effective in patients with persistent asthma","year":2005,"lang":"en","type":"article","venue":"Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"ca_institutions":"Regional Municipality of Niagara; Lakeridge Health","funders":"","keywords":"Ciclesonide; Medicine; Placebo; Inhaler; Asthma; Morning; Anesthesia; Adverse effect; Internal medicine; Inhaled corticosteroids","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003879157,0.0004173957,0.002445174,0.0002753804,0.0004369536,0.0003651012,0.0003666375,0.0007110996,0.003227674],"category_scores_gemma":[0.001159737,0.0002336461,0.0006123197,0.0003277739,0.0002968023,0.000482766,0.0001996688,0.001371102,0.0008879365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002256438,"about_ca_system_score_gemma":0.00044018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001157345,"about_ca_topic_score_gemma":0.002596638,"domain_scores_codex":[0.9998142,0.00005776428,0.00001508342,0.0000257576,0.00003951286,0.00004760364],"domain_scores_gemma":[0.9992962,0.0002381948,0.0001455817,0.00004812293,0.00004128682,0.0002306176],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1402522,0.006391106,0.04634462,0.001786202,0.000860224,0.00301567,0.0004066133,0.0004348107,0.06937553,0.0002600276,0.01181692,0.7190561],"study_design_scores_gemma":[0.08068375,0.1500695,0.7192499,0.0005911447,0.001537979,0.008588945,0.0007353621,0.001993255,0.01391761,0.0006802123,0.0218395,0.0001127224],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9505103,0.03888873,0.00132155,0.001579375,0.0003620847,0.0001831608,0.0004857609,0.0003833213,0.006285788],"genre_scores_gemma":[0.9896366,0.006386984,0.0006746913,0.0005865664,0.0003003308,0.00007539599,0.0002833038,0.00003111067,0.002025028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003227674,"threshold_uncertainty_score":0.01079768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01550903724033388,"score_gpt":0.2744191775333854,"score_spread":0.2589101402930515,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}